🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Low-grade Upper Tract Urothelial Carcinoma

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer NCT06774131Phase 379 sites📍 Homewood📍 Chandler📍 Queen Creek UroGen Pharma Ltd. · Tests: UGN-104 Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis NCT06668493Phase 1, Phase 29 sites📍 Scottsdale📍 Santa Monica📍 Jacksonville Ferring Pharmaceuticals · Tests: Nadofaragene Firadenovec Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma NCT07265947Phase 232 sites📍 Loma Linda📍 Los Angeles📍 Tampa Tyra Biosciences, Inc · Tests: Dabogratinib (TYRA-300) 60mg, Dabogratinib (TYRA-300) 80mg
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy